CPB2 Antikörper (HRP)
Kurzübersicht für CPB2 Antikörper (HRP) (ABIN2371275)
Target
Alle CPB2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- TAFI (Thrombin Activatable Fibrinolysis Inhibitor) (HRP)
-
Aufreinigung
- Purified. Prior to conjugation, this antibody preparation was solid-phase adsorbed to remove non-specific reactivities.
-
Immunogen
- Human Thrombin-activatable Fibrinolysis Inhibitor (TAFI) purified from human plasma. This protein is also referred to in the literature as Plasma Procarboxypeptidase-B and Carboxypeptidase-U.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied in a buffered stabilizer solution containing 50 % glycerol. No preservative added.
-
Konservierungsmittel
- Without preservative
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- CPB2 (Carboxypeptidase B2 (Plasma) (CPB2))
-
Andere Bezeichnung
- TAFI
-
Pathways
- Regulation of Actin Filament Polymerization, Carbohydrate Homeostasis
Target
-